155 related articles for article (PubMed ID: 31464941)
1. HPV testing on vaginal/cervical nurse-assisted self-samples versus clinician-taken specimens and the HPV prevalence, in Adama Town, Ethiopia.
Haile EL; Cindy S; Ina B; Belay G; Jean-Pierre VG; Sharon R; Lisbeth LR; Paul BJ
Medicine (Baltimore); 2019 Aug; 98(35):e16970. PubMed ID: 31464941
[TBL] [Abstract][Full Text] [Related]
2. Comparison of self-collected versus clinician collected cervicovaginal specimens for detection of high risk human papillomavirus among HIV infected women in Ethiopia.
Bogale AL; Teklehaymanot T; Ali JH; Kassie GM; Medhin G; Baye AY; Shiferaw AY
BMC Womens Health; 2022 Sep; 22(1):360. PubMed ID: 36050660
[TBL] [Abstract][Full Text] [Related]
3. Self-collected vaginal sampling for the detection of genital human papillomavirus (HPV) using careHPV among Ghanaian women.
Obiri-Yeboah D; Adu-Sarkodie Y; Djigma F; Hayfron-Benjamin A; Abdul L; Simpore J; Mayaud P
BMC Womens Health; 2017 Sep; 17(1):86. PubMed ID: 28950841
[TBL] [Abstract][Full Text] [Related]
4. Performance and pre-analytical stability of self-collected samples versus clinician cervical samples for the detection of HPV16, HPV18 and a pool of 12 other HPV types on the Roche Cobas 8800 System.
Ilardo C; Marguerettaz M; Breton A; Azzoug T; Schmitt N; Fournier R; Bayette J; Teissier G; Lelarge C; Ponseille B
New Microbiol; 2022 Apr; 45(2):111-114. PubMed ID: 35699559
[TBL] [Abstract][Full Text] [Related]
5. Dry self-sampling versus provider-sampling of cervicovaginal specimens for human papillomavirus detection in the Inuit population of Nunavik, Quebec.
Cerigo H; Coutlée F; Franco EL; Brassard P
J Med Screen; 2012 Mar; 19(1):42-8. PubMed ID: 22438506
[TBL] [Abstract][Full Text] [Related]
6. Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region.
Hesselink AT; Berkhof J; van der Salm ML; van Splunter AP; Geelen TH; van Kemenade FJ; Bleeker MG; Heideman DA
J Clin Microbiol; 2014 Mar; 52(3):890-6. PubMed ID: 24391196
[TBL] [Abstract][Full Text] [Related]
7. Self-collected versus clinician-collected cervical samples for the detection of HPV infections by 14-type DNA and 7-type mRNA tests.
Aranda Flores CE; Gomez Gutierrez G; Ortiz Leon JM; Cruz Rodriguez D; Sørbye SW
BMC Infect Dis; 2021 May; 21(1):504. PubMed ID: 34058992
[TBL] [Abstract][Full Text] [Related]
8. Uptake of Cervical Cancer Screening in Ethiopia by Self-Sampling HPV DNA Compared to Visual Inspection with Acetic Acid: A Cluster Randomized Trial.
Gizaw M; Teka B; Ruddies F; Abebe T; Kaufmann AM; Worku A; Wienke A; Jemal A; Addissie A; Kantelhardt EJ
Cancer Prev Res (Phila); 2019 Sep; 12(9):609-616. PubMed ID: 31337647
[TBL] [Abstract][Full Text] [Related]
9. Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme.
Bokan T; Ivanus U; Jerman T; Takac I; Arko D
Radiol Oncol; 2021 Jan; 55(2):187-195. PubMed ID: 33764704
[TBL] [Abstract][Full Text] [Related]
10. Implementation of HPV-based Cervical Cancer Screening Combined with Self-sampling Using a Midwifery Network Across Rural Greece: The GRECOSELF Study.
Agorastos T; Chatzistamatiou K; Tsertanidou A; Mouchtaropoulou E; Pasentsis K; Kitsou A; Moysiadis T; Moschaki V; Skenderi A; Katsiki E; Aggelidou S; Venizelos I; Ntoula M; Daponte A; Vanakara P; Garas A; Stefos T; Vrekoussis T; Lymberis V; Kontomanolis EN; Makrigiannakis A; Manidakis G; Deligeoroglou E; Panoskaltsis T; Decavalas GO; Michail G; Kalogiannidis I; Koukoulis G; Zempili P; Halatsi D; Truva T; Piha V; Agelena G; Chronopoulou A; Vaitsi V; Chatzaki E; Paschopoulos M; Adonakis G; Kaufmann AM; Hadzidimitriou A; Stamatopoulos K
Cancer Prev Res (Phila); 2019 Oct; 12(10):701-710. PubMed ID: 31427275
[TBL] [Abstract][Full Text] [Related]
11. Randomised study of HPV prevalence and detection of CIN2+ in vaginal self-sampling compared to cervical specimens collected by medical personnel.
Gustavsson I; Aarnio R; Berggrund M; Hedlund-Lindberg J; Sanner K; Wikström I; Enroth S; Olovsson M; Gyllensten U
Int J Cancer; 2019 Jan; 144(1):89-97. PubMed ID: 29943822
[TBL] [Abstract][Full Text] [Related]
12. Feasibility, validity and acceptability of self-collected samples for human papillomavirus (HPV) testing in rural Malawi.
Esber A; Norris A; Jumbe E; Kandodo J; Nampandeni P; Reese PC; Turner AN
Malawi Med J; 2018 Jun; 30(2):61-66. PubMed ID: 30627330
[TBL] [Abstract][Full Text] [Related]
13. Acceptability and Concordance of Self- Versus Clinician- Sampling for HPV Testing among Rural South Indian Women.
Madhivanan P; Nishimura H; Ravi K; Pope B; Coudray M; Arun A; Krupp K; Jayakrishna P; Srinivas V
Asian Pac J Cancer Prev; 2021 Mar; 22(3):971-976. PubMed ID: 33773563
[TBL] [Abstract][Full Text] [Related]
14. Self-obtained vaginal samples for HPV DNA testing to detect HPV-related cervical disease.
Kim MH; Jung HJ; Park SI; Kim BJ
Int J Gynaecol Obstet; 2021 Jul; 154(1):127-132. PubMed ID: 33368281
[TBL] [Abstract][Full Text] [Related]
15. Assessment of high-risk human papillomavirus infections using clinician- and self-collected cervical sampling methods in rural women from far western Nepal.
Johnson DC; Bhatta MP; Smith JS; Kempf MC; Broker TR; Vermund SH; Chamot E; Aryal S; Lhaki P; Shrestha S
PLoS One; 2014; 9(6):e101255. PubMed ID: 24978811
[TBL] [Abstract][Full Text] [Related]
16. Self-sampling as the principal modality for population based cervical screening: Five-year follow-up of the PaVDaG study.
Stanczuk GA; Currie H; Forson W; Baxter G; Lawrence J; Wilson A; Palmer T; Arbyn M; Cuschieri K
Int J Cancer; 2022 Apr; 150(8):1350-1356. PubMed ID: 34850395
[TBL] [Abstract][Full Text] [Related]
17. Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method.
Zhao FH; Lewkowitz AK; Chen F; Lin MJ; Hu SY; Zhang X; Pan QJ; Ma JF; Niyazi M; Li CQ; Li SM; Smith JS; Belinson JL; Qiao YL; Castle PE
J Natl Cancer Inst; 2012 Feb; 104(3):178-88. PubMed ID: 22271765
[TBL] [Abstract][Full Text] [Related]
18. Comparison of urine, self-collected vaginal swab, and cervical swab samples for detecting human papillomavirus (HPV) with Roche Cobas HPV, Anyplex II HPV, and RealTime HR-S HPV assay.
Cho HW; Ouh YT; Hong JH; Min KJ; So KA; Kim TJ; Paik ES; Lee JW; Moon JH; Lee JK
J Virol Methods; 2019 Jul; 269():77-82. PubMed ID: 30998958
[TBL] [Abstract][Full Text] [Related]
19. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of self-collected vaginal specimens for the detection of high-risk human papillomavirus infection and the prediction of high-grade cervical intraepithelial lesions in a high-burden, low-resource setting.
Toliman PJ; Kaldor JM; Badman SG; Phillips S; Tan G; Brotherton JML; Saville M; Vallely AJ; Tabrizi SN
Clin Microbiol Infect; 2019 Apr; 25(4):496-503. PubMed ID: 29906593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
